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Congenital Heart Disease (CHD) affects 8 births per 1,000 live births; equivalent to 1.35 million 
children born with CHD each year. Based on global incidence rate, Atrial Septal Defect (ASD), 
Ventricular Septal Defect (VSD), and Atrioventricular Septal Defect (AVSD) are found on 54.5% of 
CHD cases. Genetic factors are known to involve in CHD. Moreover, it can also be caused by 
environmental and infectious factors. Ultrasonography has been widely utilized to screen CHD at 18-22 
weeks gestational age. Screening aims to measure heart rate, heart size, heart position, four chamber of 
the heart, pericardium, atrium, ventricles, atrioventricular junctions, and ventriculoatrial junctions. 
Doppler echocardiography becomes primary diagnostic tools in CHD patients because of its high 
sensitivity and specificity, safety, and noninvasiveness. Follow-up examination is indicated on a few 
conditions. Maternal indications include autoimmune antibody, family history of defects, in vitro 
fertilization, maternal metabolic disease, or teratogenic exposure. Fetal indications include abnormal 
screening result, family history of CHD, abnormal heart rhythm, chromosomal abnormalities, 
extracardiac abnormalities, hydrops, or monochorionic twin pregnancy. With increased rate of CHD, 
better screening and follow-up should be conducted to achieve acceptable detection rate. 
Keywords: Congenital heart disease, Ultrasonography, Embryology 
 
I. INTRODUCTION 
Globally, Congenital Heart Disease 
(CHD) affects 8 births per 1,000 live births; 
equivalent to 1.35 million children born 
with CHD each year.1,2 Meanwhile, CHD 
incidence rate is higher in Asia; involving 
9.3 cases per 1,000 live birth.2 Based on 
global incidence rate, Atrial Septal Defect 
(ASD), Ventricular Septal Defect (VSD), 
and Atrioventricular Septal Defect (AVSD) 
are found on 54.5% of CHD cases.3 CHD 
incidence rate increases approximately 
10% each 5 years.2–5 
Atrial Septal Defect, VSD, and 
AVSD incidence increased from 
1970-1974 (49.2%) to 2010-2017 
(65.3%).3 CHD showed regional 
variability; Asian population study showed 
higher incidence of pulmonal outflow 
obstruction and lower incidence of left 
ventricle outflow obstruction and 
Transposition of Great Arteries (TGA).2 
Preliminary screening is able to 
detect up to 40% of CHD before 22 weeks 
gestational age, and additional screening is 
able to detect up to 80% cases of CHD.1 
Prenatal screening for congenital 
malformations, including CHD, gained 
traction from 1980s and usually conducted 
at 18-22 weeks gestational age.1,6,7   
Atrial Septal Defect, VSD, and 
AVSD are usually shown as right-to-left 
shunt in imaging studies; and depending on 
location, is categorized based on 
anatomical location of defects.1,7 Majority 
of fetus with CHD showed no heart failure 
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symptoms in utero because of placental 
circulation that provides oxygen and 
nutrition. After birth, with closure of fetal 
shunt, symptoms of heart failure may 
presents clearly.6  
Left side obstruction may present as 
systemic hypoperfusion accompanied by 
acidosis, especially in ductus-dependent 
circulation, such as in Hypoplastic Left 
Heart Syndrome (HLHS), aortic stenosis, 
and Coarctation of Aorta (CoA). During 
antenatal care, these CHD may be detected 
using three-vessel and tracheal view (3VT). 
Right-sided obstruction may present as 
significant cyanosis in case of ductus-
dependent pulmonal circulation, such as in 
pulmonal atresia.6 
Four-chamber view with outflow 
tracts allows in utero screening of 
otherwise normal four-chamber view, such 
as in Tetralogy of Fallot (ToF) and 
Transposition of Great Arteries (TGA).6 
Closure or restriction of foramen ovale may 
result in severe cyanosis and circulatory 
collapse in TGA where systemic and 
pulmonal circulation work in parallel and 
mixing of oxygenated and non-oxygenated 
blood.6 
Currently, intrauterine CHD 
detection is problematic because of 
gestational age, complex heart structure in 
imaging studies, training and experience 
needed, fetal and maternal movement, 
maternal obesity, amniotic fluids amount, 
fetal position, and maternal tissues. 
Intrauterine screening is usually done using 
ultrasonography and conducted by GP or 
OBGYN involves preliminary screening at 
18-22 weeks of gestation and follow-up 
screening to increase the accuracy (up to 
80% in CHD-focused screening).7 
Preliminary screening increases 
chance of detection and intervention; with 
ultimate goal of reducing morbidity and 
mortality of CHD. Even with trainings, 
some CHD, including Total Anomalous 
Pulmonary Venous Drainage (TAPVD), 
CoA, and progressive valvular 
abnormalities are still becoming challenge 
to detect.6 Therefore, this literature review 
aims to review the prevalence, anatomy, 




Congenital heart diseases are 
structural abnormalities in heart or major 
vessels that present during birth. Top eight 
congenital heart diseases are Ventricular 
Septal Defect (VSD), Atrial Septal Defect 
(ASD), Patent Ductus Arteriosus (PDA), 
Pulmonary Stenosis, Tetralogy of Fallot 
(ToF), Transposition of Great Arteries 
(TGA), Atrioventricular Septal Defect 
(AVSD), dan Coarctation of Aorta 
(CoA).3,8 Congenital heart diseases are 
found globally and become major health 
issues in millions of babies each year. It 
affects one-third of congenital anomalies 
found each year.2 
 
III. EPIDEMIOLOGY  
Prevalence of CHD varies in time. 
Congenital heart disease was found on 0.6 
births per 1,000 live births on 1930 and 
increasing to 9.1 births per 1,000 live births 
after 1995. The incidence increased 
markedly in 1930-1960, followed with a 
plateau of around 5.3 births per 1,000 live 
births during 1961-1975, and increased 
sharply once more in 1975-1995.2,3 
Ventricular Septal Defect, ASD, and 
PDA become three major CHD cases 
globally. These 3 lesions affect 57.9% of 
CHD cases globally and increased from 
49.2% in 1970-1974 to 65.3% in 
2010-2017.3 Regional variability exists; 
where in Asia, pulmonal outflow 
obstruction is more commonly found than 
left ventricle outflow obstruction. 
Transposition of Great Arteries is also rarer 
in Asia than in Europe, North and South 
America, and Oceania.2 
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Table 1. Global Prevalence of Congenital Heart Disease 
Subtypes of CHD Prevalence per 1,000 live births  
(95% CI) 
Percentage of subtype 
(95% CI) 
Ventricular Septal Defect 3.071 (2.845-3.305) 35.568 (33.876-37.278) 
Atrial Septal Defect 1.441 (1.215-1.687) 15.378 (13.492-17.363) 
Patent Ductus Arteriosus 1.004 (0.803-1.228) 10.172 (8.519-11.954) 
Pulmonary Stenosis 0.546 (0.485-0.611) 6.233 (5.703-6.784) 
Tetralogy of Fallot 0.356 (0.326-0.387) 4.422 (4.064-4.794) 
Transposition of Great 
Arteries 
0.295 (0.269-0.322) 3.819 (3.446-4.210) 
Atrioventricular Septal 
Defect 
0.290 (0.265-0.316) 3.595 (3.302-3.900) 
Coarctation of Aorta 0.287 (0.261-0.314) 3.570 (3.273-3.879) 
Cited from: Liu et al., 2019.3 
 
IV. RISK FACTORS  
 
CHD involves many risk factors. In a 
study conducted in Pakistan, major risk 
factors included consanguineous marriage 
(OR 2.34; 95% CI 1.61-3.38), family 
history of CHD (OR 9.43; 95% CI 
3.30-27.02), maternal comorbidities 
(OR3.9; 95% CI 1.2-5.6), and low birth 
weight (OR 3.11; 95% CI 1.84-5.29).9 
Meanwhile, based on a study in India, 
CHD risk factors included paternal age 
above 25 years old (OR 1.943; 95% CI 
1.421-2.658), no multivitamin 
consumption during pregnancy (OR 2.853; 
95% CI 2.089-3.895), history of fever in 
first trimester (OR 3.717; 95% CI 
1.625-8.501), history of obstetric issues 
(OR 2.454; 95% CI 1.565-3.848), and 
maternal age above 30 years old (OR 2.868; 
95% CI 1.255-6.555).10 
A study conducted in Shaanxi, China, 
showed similar results. Congenital heart 
disease risk factors found in Shaanxi 
included multiple pregnancy, family 
history of CHD, old maternal age, and 
parity.11 Genetic factors, including 
chromosomal and syndrome, are known to 
involve in CHD. The genetic factors are 
elaborated in Table 2. 
 
Table 2. Genetic Factors of Congenital Heart Disease 
Syndrome  Chromosomal/genetic 
abnormalities 
Common lesions Proportions  
Down  Trisomy 21 AVSD, ASD, VSD, TOF 40-50% 
Edwards Trisomy 18 VSD, ASD, DORV, TOF, CoA, 
HLHS 
90-100% 
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Patau Trisomy 13 ASD, VSD, DORV, HLHS, L-TGA, 
AVSD, TAPVR, dextrocardia, PDA 
80% 
Turner Monosomy X CoA, AS, HLHS, PAPVR 25-35% 
Klinefelter 47, XXY ASD, PDA, MVP 50% 
Cat eye Tetrasomy 22p TAPVR, PAPVR 50% 
Pallister-Kilian Tetrasomy 12p VSD, CoA, PDA, ASD, AS 25% 
Velocardiofacial Del 22q11.2 IAA(B), TA, TOF, aortic arch 
anomalies 
75-85% 
Williams  Del 7q11.23 SVAS±PVS, PS, PPS 50-80% 
Alagille JAG1, NOTCH1 (del 
20p12) 
PPS, TOF, ASD, PS 85-95% 
Noonan  PTPN11, SOS1, KRAS, 
RAF1 
PVS, ASD, CoA, HCM 80-90% 
Holt-Oram TBX5 ASD, VSD, AVSD, TOF 80% 
Char TFAP2B PDA 60% 
Ellis-van Creveld EVC, EVC2 Primum ASD, common atrium, 
AVSD 
60% 
Smith-Lemli-Opitz DHCR7 AVSD, primum ASD, VSD, PAPVR 45% 
CHARGE CHD7, SEMA3E ASD, VSD, valvular abnormalities 50-80% 
Kabuki  MLL2 CoA, ASD, VSD 40% 
Heterotaxy  ZIC3 Dextrocardia, L-TGA, AVSD, 
TAPVR 
90-100% 
ASD: atrial septal defect; AS: aortic stenosis; AVSD: atrioventricular septal defect; CoA: coarctation of aorta; 
DORV: double outlet right ventricle; HCM: hypertrophic cardiomyopathy; HLHS: hypoplastic left heart 
syndrome; IAA(B): interrupted aortic arch (type B); L-TGA: congenitally corrected transposition of great 
arteries; MVP: mitral valve prolapse; PAPVR: partial anomalous pulmonary venous return; PDA: patent ductus 
arteriosus; PPS: peripheral pulmonary stenosis; PS: pulomary stenosis; PVS: pulmonary valve stenosis; SVAS: 
supravalvular aortic stenosis; TA: truncus arteriosus; TAPVR: total anomalous pulmonary venous return; TOF: 
tetralogy of Fallot; VSD: ventricular septal defect 
Cited from: Blue, et al. 2012.12 
Besides syndromic factors, nonsyndromic genetic mutations also play parts in congenital 
heart diseases; as shown on Table 3. 
Table 3. Nonsyndromic Genetic Factors in Congenital Heart Disease 
Gene Function  Lesions  
NKX2-5 Transcription factor ASD-AV block, TF, HLHS, TGA, DORV, Ebstein 
anomaly, VSD 
NKX2-6 Transcription factor TA 
GATA4 Transcription factor ASD±PS, TOF, VSD, DORV 
GATA6 Transcription factor TA, TOF, AVSD 
TBX1 Transcription factor IAA, aortic arch anomalies, VSD 
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TBX5 Transcription factor ASD, VSD, AVSD, conduction anomalies 
TBX20 Transcription factor ASD, VSD, valvular disease, LVOTO 
CITED2 Transcription factor ASD, VSD, TOF, TGA 
ZIC3 Transcription factor Heterotaxy, ASD, AVSD, TGA, VSD, TAPVR, PS 
ZFPM2 Transcription factor TOF 
FOXH1 Transcription factor TOF, VSD 
HAND1 Transcription factor HLHS (somatic mutation) 
TFAP2B Transcription factor PDA 
NOTCH1 Membrane-ligand receptor  AS, BAV 
NODAL Membrane-ligand receptor  Heterotaxy, TGA 
JAG1 Membrane-ligand receptor  PS, TOF 
CFC1 Membrane-ligand receptor  Heterotaxy, TGA, DORV, TOF 
MYH6 Sarcomere protein ASD 
MYH7 Sarcomere protein ASD, Ebstein anomaly 
MYH11 Sarcomere protein PDA 
ACTC1 Sarcomere protein ASD, VSD 
GJA1 Gap junction protein HLHS (somatic mutation) 
GJA5 Gap junction protein TOF 
CRELD1 Cellular matrix protein AVSD, dextrocardia 
ELN Structural protein SVAS 
VEGFA Mitogen  TOF 
ASD: atrial septal defect; AS: aortic stenosis; AV: atrioventricular; AVSD: atrioventricular septal defect; BAV: 
bicuspid aortic valve; DORV: double outlet right ventricle; HLHS: hypoplastic left heart syndrome; IAA: 
interrupted aortic arch; LVOTO: left ventricular outflow tract obstruction; PDA: patent ductus arteriosus; PS: 
pulmonary stenosis; SVAS: supravalvular aortic stenosis; TA: truncus arteriosus; TAPVR: total anomalous 
pulmonary venous return; TGA: transposition of great arteries; TOF: tetralogy of Fallot; VSD: ventricular septal 
defect. Cited from: Blue et al., 2012.12 
 
Moreover, congenital heart disease can also be caused by environmental and infectious 
factors, as shown on Table 4 below. 
 
Table 4. Environmental and Infectious Factors of Congenital Heart Diseases 
Teratogen  Commonly found lesions Risks  
Maternal diabetes VSD, ASD, L-TGA, AVSD, TAPVR, CoA, TOF, 
TGA 
5% 
Maternal rubella PDA, VSD, ASD, PS, TOF 30-60% 
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Maternal phenylketonuria TOF, VSD, PDA, left heart lesions 15-50% 
Systemic lupus erythematosus Complete heart block Unknown  
Fever in pregnancy PS, left-sided and right-sided obstruction defects, 
tricuspid atresia, VSD 
Unknown  
Thalidomide TOF, ASD, VSD, TA Up to 30% 
Retinoic acids TA, TOF, IAA, DORV 25% 
Anticonvulsants All common defects Unknown  
Lithium Ebstein anomaly, tricuspid atresia  Unknown  
Selective serotonin reuptake 
inhibitors 
VSD, ASD, TOF Unknown  
Alcohol  VSD, ASD, TOF Unknown  
Marijuana  VSD, Ebstein anomaly Unknown  
ASD: atrial septal defect; AS: aortic stenosis; AV: atrioventricular; AVSD: atrioventricular septal defect; BAV: 
bicuspid aortic valve; CoA: coarcation of aorta; DORV: double outlet right ventricle; HLHS: hypoplastic left 
heart syndrome; IAA: interrupted aortic arch; LVOTO: left ventricular outflow tract obstruction; PDA: patent 
ductus arteriosus; PS: pulmonary stenosis; SVAS: supravalvular aortic stenosis; TA: truncus arteriosus; 
TAPVR: total anomalous pulmonary venous return; TGA: transposition of great arteries; TOF: tetralogy of 
Fallot; VSD: ventricular septal defect. 
Cited from: Blue et al., 2012.12 
 
V. EMBRYOLOGY OF HEART 
Formation of heart starts at third week of gestation. Cardiac cells arise from mesodermal 
layers in cranial area that migrate to primary heart field (cranial of neural folds) and start 
forming parts of atria and whole left ventricle. Right ventricle and outflow tracts arise from 
secondary heart field from visceral side of mesoderm.13,14 
 
Figure 1. Heart embryology. (A) Dorsal view of 18-days old embryo. Progenitor cells of hear migrate and form 
horseshoe-shaped primary heart field. Primary heart field forms right- and left-side of heart, including both atrium 
and whole left ventricle. Right ventricle, outflow tract, and truncus arteriosus arise from secondary heart field; 
(B) transverse view showing primary heart field in visceral mesoderm; (C) lateral cut on embryo showing primary 
heart field. Cited from: Sadler, 2019.14 
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Figure 2. Secondary heart field in visceral mesoderm. Secondary heart field creates elongation on artery and 
vein poles, that encompass right ventricle and outflow tract (conus cordis and truncus arteriosus), atrium, and 
sinus venosus. Secondary heart field defect creates shortening and outflow defect. 
Cited from: Sadler, 2019.14 
 
In the beginning, central part of 
cardiogenic area is located on the anterior 
of oropharyngeal membrane and neural 
plate. During closure of neural tube and 
formation of brain, oropharyngeal 
membrane pulled anteriorly and heart 
moves cervically before migrating to 
thorax.13,14 In time of cephalocaudal 
embryo development, embryo also folds 
laterally and creates outflow and heart 
ventricles. During embryo development, 
heart becomes whole tube consisting of 
endothelial and myocardium cells. With 
continuing development, middle section of 
mesocardium disappears, creating 
transverse pericardial sinus that connects 
both sides of pericardial cavity.14 
 
Figure 3. Cross-section of embryo in heart development; (A) 17-days old embryo; (B) 18-days old embryo; 
(C) 22-days old embryo. Fusion froms on caudal area of tube. Outflow and majority of ventricles arise from 
growth of horseshoe-shaped area before. 
Cited from: Sadler, 2019.14 
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Heart undergoes elongation from 
cells arising from secondary heart field to 
create right ventricle and outflow tracts. 
This is an important stage for outflow 
defects, including VSD, ToF, pulmonary 
atresia, and pulmonary stenosis.14 During 
outflow elongation, cardiac tube starts 
folding in 23rd day to create cardiac loop, 
finishing on 28th day.13,14 
 
Figure 4. Formation of cardiac loop; (A) 22 days; (B) 23 days; (C) 24 days; (D) frontal view of looping heart 
tube. Primitive ventricles move ventrally and to the right, while atria move dorsally and to the left. 
Cited from: Sadler, 2019.14 
 
Cardiac septum is formed on 27th day 
until 37th day. Development of tissues 
create endocardial cushions that develop 
around atrioventricular and conotruncal 
area to form septum of atrium and 
ventricles. The same process also forms 
canals and valves of atrioventricular area. 
Disruption of development in this stage 
creates ASD, VSD, TGA, and ToF.13,14 
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Figure 5. Septum on different development stages. (A, B) 30 days; (C, D) 33 days; (E) 37 days; (F, G) neonates. 
Cited from: Sadler, 2019.14 
 
Table 5. Developmental Stages and Associated Lesions 
 
Tissue  Cellular process Normal effects Abnormalities  
Primary heart field 




Formation of four 
heart chambers 
DORV, TGA, ASD, VSD, atrial 
isomerism, ventricular inversion, 
dextrocardia 
Heart tube (22nd day 
until 28th day) 
Genetic signal to 
create normal loop 
Cardiac loop Dextrocardia  
Atrioventricular 
canal, endocardial 
cushions (26th day 







to right and left canal, 
formation of mitral 




VSD, mitral and tricuspid defect 
Secondary heart field 
(22nd day until 28th 
day) 
Visceral mesoderm 
from ventral pharynx 
and signals from 
neural crest cells 
Elongation and 
separation of outflow 
into aortic and 
pulmonary canal 
ToF, TGA, pulmonary atresia, 
pulmonary stenosis 
Outflow tract (36th 
day until 49th day) 





and division of 
outflow tract 
Common truncus arteriosus, outflow 
defect  
Aortic arch (22nd day 
until 42nd day) 
Migration of neural 
crest cell, 
proliferation 
Formation of aortic 
arch  
Anomalous right pulmonary artery 
Cited from: Sadler, et al.14 
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VI. ULTRASONOGRAPHY FINDINGS 
Ultrasonography has been widely 
utilized to screen CHD at 18-22 weeks 
gestational age.15,16 In Great Britain, 
detection rate of CHD was 35%. In United 
Kingdom, 35% of CHD was able to be 
prenatally detected, while in Northern 
Ireland the detection rate was 32%. In 
Scotland, the detection rate was 36%, while 
in Wales the detection rate was 52%. In 
Great Britain, the number is lower than the 
target of 60% detection rate.16 
In a national study in Czech, around 
one-third of CHD could be screened 
prenatally. The detection rate was 77.3% 
for double outlet right ventricle, 50.6% for 
left heart hypoplasia, 50% for Ebstein 
anomaly, 42.9% for AVSD, and 42.5% for 
single ventricle. However, ASD, VSD, and 
pulmonary stenosis rate was low; 0.8%, 
2.4%, and 3.2%, respectively.15 
In a study in Brazil, detection rate of 
CHD is only 9.96%. From this number, 
48.1% were complex cases (left heart 
hypoplasia, tricuspid atresia, Ebstein 
anomaly, truncus arteriosus), 18.5% were 
significant cases (ToF, large VSD, tricuspid 
dysplasia, large pulmonary stenosis), 7.4% 
were minor cases (small VSD), and 26% 
were not categorized (cardiomyopathy, 
dysrhythmia, and others).17 
Congenital heart diseases screening 
can be done starting from 11 weeks 
gestational age using four-chamber view. 
After that, screening can be conducted from 
second trimester to follow-up any septal or 
developmental defects. Sensitivity of CHD 
may approach 92% in 13th week of 
gestation.7 
 
Figure 6. Four-chamber view in early gestation. (A) Four-chamber view in 13th week; (B) Four-chamber view 
with Doppler in 13th week. 
Cited from: Norton et al.7 
 
Second trimester screening aims to 
detect CHD. Screenings are usually done at 
week 18-22 gestational age. Screening 
aims to measure heart rate, heart size, heart 
position, four chamber of the heart, 
pericardium, atrium, ventricles, 
atrioventricular junctions, and 
ventriculoatrial junctions.7 Early detection 
of CHD is paramount because of clinical 
complications that may arise shortly after 
birth. 
Doppler echocardiography becomes 
primary diagnostic tools in CHD patients 
because of its high sensitivity and 
specificity, safety, and noninvasiveness.6,18 
Echocardiography starts from 
determination of heart location, followed 
by four-chamber view, left ventricular 
outflow tract view, right ventricular 
outflow tract view, and three-vessel view or 
three-vessel tracheal view.6 Goals of these 
examinations are to measure heart shape 
and abnormalities.19 
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Figure 7. Main axis of fetal heart screening. I: most caudal plane, showing fetal stomach (St), descending aorta 
cross section (dAo), spine (Sp), and fetal liver (Li). II: four-chamber view of fetal heart, showing right and left 
ventricle (RV, LV), atria (RA, LA), foramen ovale (FO), and pulmonary veins beside descending aorta. III: left 
ventricular outflow tract view, showing aorta (Ao), LV, RV, LA, and RA with descending aorta cross section 
(dAo). IV: most cephalad position (right ventricular outflow tract view) showing pulmonary artery (MPA) and its 
branches (RPA dan LPA), ascending aorta (Ao), and descending aorta (dAo). V: three vessels tracheal view show 
superior vena cava (SVC), pulmonary artery (PA), ductus arteriosus (DA), aortic arch (Ao-dAo), and trachea (Tr).  
Cited from: The International Society of Ultrasound in Obstetrics, 2013.19 
 
Heart location screening is essential 
to measure heart orientation. In situs 
inversus, other lesions can sometimes be 
found; therefore, more detailed screening is 
warranted. Four-chamber view is used to 
measure heart location and anomalies, 
surrounding tissue lesion, ToF, 
cardiomegaly, and septal or valvular 
defects. 6,20 Four-chamber view is also 
utilized to measure fetal heart rhythm and 
fetal heart rate. Persistent bradycardia may 
arise from heart block. Abnormal heart 
location may also come from abnormalities 
in thorax cavity, such as diaphragmatic 
hernia or pulmonary hypoplasia.19 
Left ventricular outflow tract view is 
utilized to detect valvular defect, aortal 
defect, and ventricular septal defect. Right 
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ventricular outflow tract view is used to 
measure right heart outflow, including 
pulmonary valve, pulmonary stenosis, and 
TGA.6,18–20 
Three-vessels view and three-vessel 
tracheal view is used to locate any 
congenital heart defects and to confirm 
defects shown in four-chamber view. 
Three-vessels view is also used to aid 
diagnosis in syndromic chromosomal 
abnormalities.6,18,20 
Follow-up examination is indicated 
on a few conditions. Maternal indications 
include autoimmune antibody, family 
history of defects, in vitro fertilization, 
maternal metabolic disease, or teratogenic 
exposure. Fetal indications include 
abnormal screening result, family history of 
CHD, abnormal heart rhythm, 
chromosomal abnormalities, extracardiac 










































Figure 8. Four-chamber view on second trimester. (A) Diagram; (B-F) Ultrasonographic findings.  
Cited from: Norton, 2008.7 
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Table 6. Congenital Heart Lesions and Clinical Symptoms 
Lesions Prevalence per 
10,000 live births 
Hypoxemia  Ductus arteriosus 
dependent 
Tetralogy of Fallot 5.1 Majority  Rare   
Transposition of great arteries 4.0 All  Rare  
Double-outlet right ventricle 1.7 Some  Not  
Truncus arteriosus 1.0 All   Not  
Total anomalous pulmonary venous 
connection 
1.2 All Not  
Ebstein anomaly 0.6 Some Sone 
Tricuspid atresia 0.5 All Some 
Pulmonary atresia, intact septum 0.8 All All   
Pulmonary stenosis/atresia  6.3 Some  Some 
Right heart hypoplasia  3.3 all  All 
Coarctation of aorta 4.7 Some  Some 
Aortic arch atresia/hypoplasia 1.0 Some  All    
Aortic valve stenosis 1.6 Rare   Some 
Other defects 12.4 Some   Some 




Congenital heart disease is a major 
health concern, affecting 1.35 million 
children born every year. With increased 
rate of CHD, better screening and follow-
up should be conducted to achieve 
acceptable detection rate. Ventricular septal 
defect, ASD, and AVSD are found in 
57.9% cases of CHD globally and 
increasing. Their risk factors include 
consanguineous marriage, family history of 
CHD, old maternal and paternal age, and 
exposure to teratogens. Genetic factors, 
including chromosomal or syndromic 
conditions, are known to manifest as CHD.  
Missteps in cardiac development are 
the main pathophysiology of CHD. 
Ultrasonography screening in 18-22 weeks 
gestational age can be utilized to screen 
developmental issues. Follow-up screening 
can be conducted to increase detection rate 
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